Key Takeaways
- Record revenue, broad-based recovery: Revenue hit an all-time high of ₹281 cr, driven by a recovering US customer base and expanding Indian market presence, with momentum accelerating through the year.
- Operating leverage is kicking in meaningfully: EBITDA margin jumped 462 bps YoY to 12.3% as a largely fixed cost structure translated revenue growth directly into profitability; PAT surged 265% YoY.
- Guidance raised across the board: FY25 revenue growth guidance lifted to 22–24% (from 16–20%) and gross margin guidance raised to 34–36%, reflecting confidence in the order pipeline and execution.
- US plant drag is shrinking but persists: The US facility loss narrowed to ~₹3.4 cr from ₹14 cr in Q1, yet it remains a margin headwind; management calls it an essential beachhead and insurance policy, not a near-term profit center.
- What to watch next quarter: Whether the Q4 implied 40–48% growth materializes, the pace of working capital normalization from 150 days, and any concrete detail on the new industry verticals management is entering.
Revenue Growth & Demand Drivers
- Broad-based momentum: Growth spanned industrials (+57% YoY), clean energy (+53% YoY), and mobility (+10% YoY); communications saw a slight slowdown but recovery is expected in coming quarters.
- US customer base recovering: Existing US customers who had slowed down a year ago are returning at better-than-present levels, and some new customers will start this quarter.
- India market scaling: Indian rail business is scaling well with stronger performance expected next year; railways saw tremendous growth this year and new products have been added to the portfolio.
- New wins moving to production: Wins in industrial, automotive, and aerospace are transitioning from design and prototype to commercial production, with ramp-up expected in upcoming quarters.
- Clean energy ramp-up on track: Commercial production for large US clean energy customers begins in Q4, with ramp-up starting in Q1; management is taking a "very conservative number" on it.
- Mexico-to-India shift emerging: Avalon is seeing activity from products moving from Mexico to India as customers reassess risk profiles and find the US expensive, a trend management calls a "pleasant surprise."
- Order intake healthy: Quarterly order intake is in the ₹350–₹400 cr range, with a healthy mix across verticals; industrials performed very well and are expected to continue.
Kunhamed Bicha: "Absolutely. You have seen the 30% growth rate already in the last four quarters. And we think it will be a little bit better this quarter. And we are confident, we have set up our operations and leadership, the factories to have this sustained higher growth."
Margin & Profitability
- Gross margin industry-leading: Gross margin reached 37.3%, up 48 bps YoY; management maintains this by focusing on long-term profitable growth and staying away from short-term, low-margin business.
- EBITDA leverage structural: A significant portion of the cost structure is fixed, so revenue growth translates directly into enhanced profitability; PAT margin reached 8.2%, up 521 bps YoY.
- India plants highly profitable: India plants, which contribute 88% of revenue, delivered an EBITDA margin of 15% and PAT margin of 10.8%.
- US business still a drag: The US facility continues to weigh on consolidated margins due to negative operating leverage, though the loss has narrowed dramatically from a year ago; management views it as a beachhead for engineering interactions and customer conversations, not a near-term profit driver.
- Box-build margin caution: Management is pushing for higher and more complex box-build work but wants to "guide lower" on margin expectations from that mix shift.
- Sustainable EBITDA assumption: Management indicated 12% EBITDA margin is a "decent assumption" for the near term, while noting they always strive to do better.
Kunhamed Bicha: "We always have said that we are not going to do growth at all costs. We are going to do profitable growth, in the sense we are not going to sign businesses for the top line."
US Strategy & Geopolitical Positioning
- US plant as beachhead and insurance: The US facility serves dual purposes: it eases customer onboarding by providing local service levels, and it acts as an insurance policy if political conditions force manufacturing back to the US.
- India-first manufacturing shift: Customers are increasingly coming directly to India for EMS work, a change from a decade ago when they needed to stop in the US first; the move to India was made a year before the US election, which management calls fortunate.
- Tariff risk manageable: If tariffs are imposed, Avalon can manufacture in the US at a higher cost and pass that through; management sees Trump's tariff rhetoric as "more of a negotiating tool" than a structural shift.
- Customer tone unchanged: Every meeting starts with talk of Trump, but product complexity and life terms of 5–15 years mean customers are unlikely to move just because of a change in governance; changes take a year or two to implement.
Kunhamed Bicha: "The way we look at it is, the customers got both options, you can pay a higher price in the U.S., if they want to do it in the U.S. But today with India's emergence as an EMS location, we are seeing customers come directly rather than what it was 10 years back, you needed to stop in the U.S. and then come here."
Capacity Expansion & New Verticals
- Chennai export plant operational: The new Chennai plant dedicated for export is complete, fully operational, and already starting to see revenues.
- Brownfield expansion progressing: Phase 1 of brownfield expansion in Chennai for the domestic market is finished; Phase 2 is expected to begin within the next 1–2 quarters and will take six to nine months to complete from start.
- Capacity built ahead of demand: Management builds buildings 9–12 months ahead of business; a building under construction now will be utilized nine months from now.
- New industry verticals targeted: Avalon is entering a couple of new industries with the same business model; details will be discussed "a few quarters later."
- Kavach anti-collision opportunity: Avalon is actively working with customers on Kavach systems for Indian Railways; some products have been built and approved, field trials are ongoing, and Stage 2 or Stage 3 should see significant business.
- Design services without IP ownership: Avalon runs a design-as-a-service operation with 150–200 people but deliberately avoids owning IP, as that would be "counterproductive" and drive away the five other customers for whom they build similar products.
Kunhamed Bicha: "Sometimes it's very counterproductive because, let's say, we are doing five different type of inverters, for the sake of argument, for the best guys in the world. And if we have our own inverter design, the other five will not stay with us."
Balance Sheet & Cash Flow
- Working capital temporarily elevated: Net working capital days rose from 134 in September to 150 in December due to a temporary increase in receivable days from 80 to 94; management says this is a timing phenomenon tied to increased sales, not collection challenges.
- Receivables already collected: The elevated receivables were from large MNC and Fortune 500 customers and were collected in the first fortnight of January.
- Reduction target maintained: Management is confident of reducing net working capital by 10–15 days by March 2025 from the March 2024 baseline, through a combination of receivables, payables, and inventory improvements.
- Positive cash flow ahead: With increasing sales and positive operating leverage, the company should start seeing positive cash flow from operations in coming quarters.
- CAPEX run-rate steady: Annual CAPEX is expected to remain at ₹40–₹45 cr for the foreseeable future; management would look at it differently only if "substantial breaks" requiring more investment emerge.
- Cash preserved for opportunity: Management is hoping to see "some substantial business" that would require cash in the next year or so; otherwise, CAPEX stays at the steady run-rate.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| FY25 revenue growth | 22%–24% YoY | Full year FY25 |
| FY25 gross margin | 34%–36% | Full year FY25 |
| Net working capital reduction | Reduce by 10–15 days from March 2024 baseline | By March 2025 |
| Brownfield Phase 2 start | Construction to begin | Within next 1–2 quarters |
| Brownfield Phase 2 completion | Six to nine months from start | From Phase 2 start date |
| Clean energy commercial production | Begin commercial production for US customers | Q4 FY25 |
| Clean energy ramp-up | Volume ramp-up begins | Q1 FY26 |
| US plant PAT-positive | Could become PAT-positive | Next 12–18 months |
| Sustained higher growth | 25% YoY growth continuing, with 30%+ rate seen in last four quarters improving slightly | Next 12–18 months |
| Annual CAPEX | ₹40–₹45 cr per year | Foreseeable future |
Key Metrics
| Metric | Q3 FY25 |
|---|---|
| Revenue | ₹281 cr, +31.07% YoY from ₹214 cr in Q3 FY24 |
| Revenue growth guidance FY25 | 22% to 24%, raised from 16%–20% |
| Gross margin | 37.3%, +48 bps YoY from 36.8% |
| Gross margin guidance FY25 | 34% to 36%, raised from 33%–35% |
| EBITDA | ₹34.6 cr, +110% YoY from ₹16.5 cr |
| EBITDA margin | 12.3%, +462 bps YoY from 7.7% |
| PAT | ₹24 cr, +264.9% YoY from ₹6.6 cr |
| PAT margin | 8.2%, +521 bps YoY from 3% |
| Order book | ₹1,594 cr, +25% YoY, avg execution 12–14 months |
| Long-term contracts | ₹1,111 cr, +32% YoY, avg execution 2–3 years |
| Net working capital days | 150 days, improved from 161 days in Mar 2024; increased from 134 days in Sep 2024 |
| Trade receivables days | 94 days, up from 79 days in Mar 2024 and 80 days in Sep 2024 |
| Net inventory days | 103 days, down from 118 days in Mar 2024 |
| US plant revenue share | 12% of Q3 FY25 revenue, net loss of ~₹3.4 cr improved from ₹14 cr loss in Q1 FY25 |
| India plants EBITDA margin | 15%, representing 88% of Q3 FY25 revenue |
| Clean energy segment growth | +53% YoY, representing 22% of business |
| Industrial segment growth | +57% YoY |
| CAPEX | ₹11.3 cr in Q3 FY25; ₹32.7 cr in 9M FY25 |
| Asset turns | 8.8 |